Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells

Estrogen receptors (ERs), which mediate the proliferative action of estrogens in breast cancer cells, are ligand-dependent transcription factors that regulate expression of their primary target genes through several mechanisms. In addition to direct binding to cognate DNA sequences, ERs can be recruited to DNA through other transcription factors (tethering), or affect gene transcription through modulation of signaling cascades by non-genomic mechanisms of action. To better characterize the mechanisms of gene regulation by estrogens, we have identified more than 700 putative primary and about 1300 putative secondary target genes of estradiol in MCF-7 cells through microarray analysis performed in the presence or absence of the translation inhibitor cycloheximide. Although siRNA-mediated inhibition of ERα expression antagonized the effects of estradiol on up- and down-regulated primary target genes, estrogen response elements (EREs) were enriched only in the vicinity of up-regulated genes. Binding sites for several other transcription factors, including proteins known to tether ERα, were enriched in up- and/or down-regulated primary targets. Secondary estrogen targets were particularly enriched in sites for E2F family members, several of which were transcriptionally regulated by estradiol, consistent with a major role of these factors in mediating the effects of estrogens on gene expression and cellular growth.

[1]  George Reid,et al.  Transcription in four dimensions: nuclear receptor‐directed initiation of gene expression , 2006, EMBO reports.

[2]  C. Tohyama,et al.  Modulation of oestrogen receptor signalling by association with the activated dioxin receptor , 2003, Nature.

[3]  Takeshi Funakoshi,et al.  G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. , 2006, Biochemical and biophysical research communications.

[4]  S. Orkin,et al.  Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor , 1995, Molecular and cellular biology.

[5]  Toshio Nikaido,et al.  Expression of Replication-Licensing Factors MCM2 and MCM3 in Normal, Hyperplastic, and Carcinomatous Endometrium: Correlation With Expression of Ki-67 and Estrogen and Progesterone Receptors , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[6]  K. Helin,et al.  Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription , 2005, Nucleic acids research.

[7]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[8]  Z. Ronai,et al.  Ubiquitin and SUMO systems in the regulation of mitotic checkpoints. , 2006, Trends in biochemical sciences.

[9]  Tatiana Tatusova,et al.  NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..

[10]  Twyla T. Pohar,et al.  ERTargetDB: an integral information resource of transcription regulation of estrogen receptor target genes. , 2005, Journal of molecular endocrinology.

[11]  M. Parker,et al.  Nuclear Receptors A Rendezvous for Chromatin Remodeling Factors , 2003, Cell.

[12]  Eric R. Prossnitz,et al.  A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.

[13]  A. Hanberg,et al.  The basic helix–loop–helix–PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Allen Chong,et al.  Discovery of estrogen receptor α target genes and response elements in breast tumor cells , 2004, Genome Biology.

[15]  Arul M Chinnaiyan,et al.  Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors , 2006, Genome Biology.

[16]  Marc E. Lippman,et al.  GREB1 is a critical regulator of hormone dependent breast cancer growth , 2005, Breast Cancer Research and Treatment.

[17]  J E Paciga,et al.  Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. , 2001, Cancer research.

[18]  Terrence S. Furey,et al.  The UCSC Genome Browser Database , 2003, Nucleic Acids Res..

[19]  John H. White,et al.  Opposite Effects of Histone Deacetylase Inhibitors on Glucocorticoid and Estrogen Signaling in Human Endometrial Ishikawa Cells , 2005, Molecular Pharmacology.

[20]  J. Trimarchi,et al.  E2F-6, a member of the E2F family that can behave as a transcriptional repressor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Lupien,et al.  Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor α , 2006, Molecular Pharmacology.

[22]  Barry Komm,et al.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. , 2003, Endocrinology.

[23]  K. Helin,et al.  E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription , 1998, Oncogene.

[24]  D. Haussler,et al.  Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. , 2005, Genome research.

[25]  K. Korach,et al.  Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.

[26]  John H. White,et al.  Regulation of GREB1 Transcription by Estrogen Receptor α through a Multipartite Enhancer Spread Over 20 kb of Upstream Flanking Sequences* , 2007, Journal of Biological Chemistry.

[27]  Yoshiyuki Kuchino,et al.  Guanine Nucleotide Exchange Factor, Tiam1, Directly Binds to c-Myc and Interferes with c-Myc-mediated Apoptosis in Rat-1 Fibroblasts* , 2003, The Journal of Biological Chemistry.

[28]  J. Dong,et al.  Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. , 2005, Endocrinology.

[29]  D. A. Foster,et al.  Myc stabilization in response to estrogen and phospholipase D in MCF‐7 breast cancer cells , 2006, FEBS letters.

[30]  Lucia Altucci,et al.  A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. , 2004, Journal of molecular endocrinology.

[31]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[32]  S. Safe.  Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. , 2001, Vitamins and hormones.

[33]  D. Henley,et al.  Estrogens and cell-cycle regulation in breast cancer , 2001, Trends in Endocrinology & Metabolism.

[34]  Helmut Dotzlaw,et al.  Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. , 1998, Cancer research.

[35]  V. Laudet,et al.  The nuclear receptor superfamily , 2003, Journal of Cell Science.

[36]  T. Schlange,et al.  Novel c‐MYC target genes mediate differential effects on cell proliferation and migration , 2007, EMBO reports.

[37]  M. Parker,et al.  Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. , 2001, Journal of molecular endocrinology.

[38]  F. Dilworth,et al.  Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription , 2001, Oncogene.

[39]  K. Helin,et al.  E2F7, a novel E2F featuring DP‐independent repression of a subset of E2F‐regulated genes , 2003, The EMBO journal.

[40]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..

[41]  J. Chen,et al.  The SRC family of nuclear receptor coactivators. , 2000, Gene.

[42]  V. Jordan.  Estrogen, selective estrogen receptor modulation, and coronary heart disease: something or nothing. , 2001, Journal of the National Cancer Institute.

[43]  P. Chambon,et al.  Defining a minimal estrogen receptor DNA binding domain. , 1993, Nucleic acids research.

[44]  J. Liao,et al.  Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system Interaction of estrogen receptor α with phosphatidylinositol 3-OH kinase , 2002, Steroids.

[45]  D. Agard,et al.  Estrogen receptor pathways to AP-1 , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[46]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[47]  V. Giguère,et al.  Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells. , 2003, Molecular endocrinology.

[48]  D. Kalaitzidis,et al.  Transcription factor cross-talk: the estrogen receptor and NF-κB , 2005, Trends in Endocrinology & Metabolism.

[49]  Guillaume Bourque,et al.  Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sites , 2006, Genome Biology.

[50]  S. Andò,et al.  The G Protein-coupled Receptor GPR30 Mediates c-fos Up-regulation by 17β-Estradiol and Phytoestrogens in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.

[51]  R. Sutherland,et al.  c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry , 1998, Molecular and Cellular Biology.

[52]  G. Sathya,et al.  Sequence Requirements for Estrogen Receptor Binding to Estrogen Response Elements* , 1998, The Journal of Biological Chemistry.

[53]  T. Collins,et al.  Early growth response factor 1: a pleiotropic mediator of inducible gene expression , 1998, Journal of Molecular Medicine.

[54]  Martin C Frith,et al.  Genomic targets of nuclear estrogen receptors. , 2004, Molecular endocrinology.

[55]  Neil J. McKenna,et al.  Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.

[56]  Clifford A. Meyer,et al.  Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1 , 2005, Cell.

[57]  A. Wärri,et al.  Involvement of estrogen receptor β in terminal differentiation of mammary gland epithelium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  B. McEwen,et al.  Estrogen actions in the central nervous system. , 1999, Endocrine reviews.

[59]  Simak Ali,et al.  Endocrine-responsive breast cancer and strategies for combating resistance , 2002, Nature Reviews Cancer.

[60]  Gordon K. Smyth,et al.  affylmGUI: a graphical user interface for linear modeling of single channel microarray data , 2006, Bioinform..

[61]  G. Ryffel,et al.  A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. , 1988, Nucleic acids research.

[62]  R. Blomhoff,et al.  A robust characterization of retinoic acid response elements based on a comparison of sites in three species , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[63]  C. Glass,et al.  Coregulator Codes of Transcriptional Regulation by Nuclear Receptors* , 2001, The Journal of Biological Chemistry.

[64]  Lihua Liu,et al.  TRED: a Transcriptional Regulatory Element Database and a platform for in silico gene regulation studies , 2004, Nucleic Acids Res..

[65]  M. Kurokawa,et al.  Oncogenic mechanisms of Evi-1 protein , 2001, Cancer Chemotherapy and Pharmacology.

[66]  K. Georgopoulos,et al.  Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes , 1999, The EMBO journal.

[67]  Chien-Cheng Chen,et al.  Egr‐1 is activated by 17β‐estradiol in MCF‐7 cells by mitogen‐activated protein kinase‐dependent phosphorylation of ELK‐1 , 2004, Journal of cellular biochemistry.

[68]  David J. Arenillas,et al.  oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes , 2005, Nucleic acids research.

[69]  E. Levin,et al.  Nature of functional estrogen receptors at the plasma membrane. , 2006, Molecular endocrinology.

[70]  B. van der Burg,et al.  Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. , 1989, Molecular and cellular endocrinology.

[71]  C. Klinge,et al.  Response element sequence modulates estrogen receptor alpha and beta affinity and activity. , 2002, Journal of molecular endocrinology.

[72]  C. Klinge.  Estrogen receptor interaction with estrogen response elements. , 2001, Nucleic acids research.

[73]  D. Kalaitzidis,et al.  Transcription factor cross-talk: the estrogen receptor and NF-kappaB. , 2005, Trends in endocrinology and metabolism: TEM.

[74]  M. Brown-Luedi,et al.  Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes. , 1984, Nucleic acids research.

[75]  L. Freedman,et al.  Mediator complexes and transcription. , 2001, Current opinion in cell biology.

[76]  Takashi Nakamura,et al.  Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. , 2006, Endocrine journal.

[77]  John H. White,et al.  Genome-wide identification of high-affinity estrogen response elements in human and mouse. , 2004, Molecular endocrinology.

[78]  John H. White,et al.  Widespread Alu repeat-driven expansion of consensus DR2 retinoic acid response elements during primate evolution , 2007, BMC Genomics.

[79]  A. Sandelin,et al.  Applied bioinformatics for the identification of regulatory elements , 2004, Nature Reviews Genetics.

[80]  J. Gustafsson.  ERβ scientific visions translate to clinical uses , 2006 .

[81]  C. Hughes,et al.  Integration of the Non-genomic and Genomic Actions of Estrogen , 2002, The Journal of Biological Chemistry.

[82]  J. Gustafsson,et al.  Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. , 2001, Cancer research.

[83]  John W. R. Schwabe,et al.  The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements , 1993, Cell.

[84]  P. Bontempo,et al.  Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells. , 1996, The EMBO journal.

[85]  J. Carroll,et al.  Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. , 2003, Endocrine-related cancer.

[86]  S. Mader,et al.  Rational design of an estrogen receptor mutant with altered DNA-binding specificity , 2007, Nucleic acids research.

[87]  J. Thomsen,et al.  Mechanisms of estrogen action. , 2001, Physiological reviews.

[88]  Tatiana A. Tatusova,et al.  NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..

[89]  John H. White,et al.  Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. , 2005, Molecular endocrinology.

[90]  L. Murphy,et al.  Altered Estrogen Receptor α and β Messenger RNA Expression during Human Breast Tumorigenesis , 1998 .

[91]  David M. Livingston,et al.  A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells , 2002, Science.

[92]  E. Simpson.  Sources of estrogen and their importance , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[93]  S. Squazzo,et al.  A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data--a case study using E2F1. , 2006, Genome research.

[94]  John H. White,et al.  Diversity in the mechanisms of gene regulation by estrogen receptors. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[95]  Robert Gentleman,et al.  Analyzing factorial designed microarray experiments , 2004 .

[96]  K. Bland,et al.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. , 2000, Molecular endocrinology.

[97]  Donald P. McDonnell,et al.  Connections and Regulation of the Human Estrogen Receptor , 2002, Science.

[98]  V. Sukhatme,et al.  Early transcriptional events in cell growth: the Egr family. , 1990, Journal of the American Society of Nephrology : JASN.

[99]  L. Murphy,et al.  Estrogen receptor diminishes DNA-binding activities of chicken GATA-1 and CACCC-binding proteins. , 1997, DNA and cell biology.